This study analyses existing HTA and reimbursement procedures within EUnetHTA partner countries. It identifies how within their existing procedures agencies in these countries can:
- Engage in HTA cooperation
- Use jointly produced HTA information
- Re-use national, regional and local HTA information from other jurisdictions
The study includes procedures for assessing pharmaceuticals and nonpharmaceutical health technologies in inpatient and outpatient settings. It includes agencies that produce HTAs and also agencies using HTA type information provided by other parties to support decision-making.